| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2006-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc982ef4f87623f78953de0ad0cd214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17154301a1585c1179092b819ccc01b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd3090b48f1109bfd1270a8fcead3b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0b5ed9f4b007dd5e18f6592d94c883f |
| publicationDate |
2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006316075-A |
| titleOfInvention |
Piperazine sodium and tazobactam sodium injection premix formulations |
| abstract |
A novel liquid form of pre-mixed piperacillin for use in parenteral administration to combat multiple microbial infections in a patient. A pharmaceutical composition suitable for parenteral administration, the pharmaceutical composition having an effective amount of piperacillin and a pH adjusted to a range of about 6.1 to about 6.9. Contains solution. In one embodiment, the effective amount of piperacillin is provided in the form of piperacillin sodium and the concentration of piperacillin is in the range of about 20 to about 80 mg / ml solution. [Selection figure] None |
| priorityDate |
1999-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |